Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOVASTATIN vs LUBIPROSTONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOVASTATIN vs LUBIPROSTONE: Safety Overview

Metric LOVASTATIN LUBIPROSTONE
Total FAERS Reports 1,387 1,214
Deaths Reported 204 118
Death Rate 14.7% 9.7%
Hospitalizations 287 332
Average Patient Age 60.2 yrs 64.0 yrs
% Female Patients 55.9% 66.5%
FDA Approval Date Apr 14, 2006 Apr 29, 2008
Manufacturer Preferred Pharmaceuticals, Inc. Direct_Rx
Route ORAL ORAL
Marketing Status Discontinued Prescription